Back to Newsroom

Boston Herald: Norwood company tests immune reset drug

A Norwood pharmaceutical company is launching three phase-two studies this summer to test a medication for illnesses that cause debilitating inflammation, including cystic fibrosis — a deadly inherited disease with few treatments.

“There are so many of these diseases, and we keep finding out more and more about them,” said Yuval Cohen, CEO of Corbus Pharmaceuticals. “There is a tremendous unmet need.”

Click here to read more